COMMUNIQUÉ DE PRESSE publié le 11/08/2025 à 07:00, il y a 9 mois 15 jours Relief Therapeutics Advances Publication of 2025 Half-Year Report Relief Therapeutics advances publication of its 2025 half-year report from August 27 to August 14, 2025, indicating completion ahead of schedule. Company to provide shareholder update and financial statements Biopharmaceutical Relief Therapeutics Publication Innovative Treatment Options 2025 Half-Year Report
BRÈVE publiée le 29/07/2025 à 07:05, il y a 9 mois 28 jours Relief Therapeutics and NeuroX to Merge, Expanding AI Health Tech SIX Swiss Exchange Mergers & Acquisitions Neurological Diseases AI Health Tech MindMaze
BRÈVE publiée le 29/07/2025 à 07:05, il y a 9 mois 28 jours Relief Therapeutics et NeuroX fusionnent, développant ainsi leur technologie de santé basée sur l'IA SIX Swiss Exchange Fusions Et Acquisitions Maladies Neurologiques MindMaze Technologie De La Santé Basée Sur L'IA
COMMUNIQUÉ DE PRESSE publié le 29/07/2025 à 07:00, il y a 9 mois 28 jours Relief Therapeutics Announces Proposed Business Combination with NeuroX, successor to MindMaze Relief Therapeutics to merge with NeuroX, successor to MindMaze, creating a SIX-listed, AI-driven health tech company. Transaction expected to close in Q4 2025 Business Combination Relief Therapeutics MindMaze NeuroX AI-driven Health Tech
BRÈVE publiée le 20/06/2025 à 07:05, il y a 11 mois 6 jours Relief Therapeutics Faces FDA Setback for RLF-TD011 QIDP Designation RLF-TD011 Orphan Drug FDA Response Epidermolysis Bullosa QIDP Designation
BRÈVE publiée le 20/06/2025 à 07:05, il y a 11 mois 6 jours Relief Therapeutics fait face à un revers de la FDA concernant la désignation QIDP du RLF-TD011 RLF-TD011 Médicament Orphelin Réponse De La FDA Epidermolyse Bulleuse Désignation QIDP
COMMUNIQUÉ DE PRESSE publié le 20/06/2025 à 07:00, il y a 11 mois 6 jours Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011 Relief Therapeutics receives FDA response on QIDP request for RLF-TD011, impacting EB treatment strategy with Orphan Drug and Rare Pediatric Disease designations Relief Therapeutics RLF-TD011 FDA Response Epidermolysis Bullosa QIDP Request
BRÈVE publiée le 12/06/2025 à 11:05, il y a 11 mois 14 jours Relief Therapeutics Announces Results of Annual General Meeting Financial Statements Shareholder Approval Annual Meeting Board Elections Compensation Approval
BRÈVE publiée le 12/06/2025 à 11:05, il y a 11 mois 14 jours Relief Therapeutics annonce les résultats de son assemblée générale annuelle États Financiers Réunion Annuelle Approbation Des Actionnaires Élections Du Conseil D'administration Approbation De L'indemnisation
COMMUNIQUÉ DE PRESSE publié le 12/06/2025 à 11:00, il y a 11 mois 14 jours Relief Therapeutics Announces Results of Annual General Meeting Relief Therapeutics announces results of its Annual General Meeting with shareholders approving all proposals by a large majority. AGM covers key agenda items and re-election of board members and auditors Board Of Directors Annual General Meeting Shareholders Relief Therapeutics AGM Results
Publié le 26/05/2026 à 07:59, il y a 5 heures 6 minutes Saint-Gobain signe un accord de cession de son activité de distribution de carrelage dans les pays nordiques
Publié le 26/05/2026 à 07:59, il y a 5 heures 6 minutes Saint-Gobain has signed an agreement for the sale of its Tiles Distribution business in the Nordics
Publié le 25/05/2026 à 18:00, il y a 19 heures 5 minutes Déclaration des transactions sur actions propres réalisées du 18/05/2026 au 24/05/2026
Publié le 25/05/2026 à 17:45, il y a 19 heures 20 minutes Déclaration hebdomadaire de rachat d'actions
Publié le 26/05/2026 à 11:00, il y a 2 heures 5 minutes American Critical Minerals Receives Final BLM Potash Prospecting Permits for 2026 Drill Program at Green River Project
Publié le 26/05/2026 à 10:20, il y a 2 heures 45 minutes Preparing the Market: What MoTA Is Meant to Solve
Publié le 26/05/2026 à 10:00, il y a 3 heures 5 minutes UraniumX Commences Drill Program at Murphy Lake
Publié le 26/05/2026 à 09:01, il y a 4 heures 4 minutes Star Copper Announces Early Season Mobilization and Drill Program Update at Star Project
Publié le 26/05/2026 à 08:02, il y a 5 heures 3 minutes Southern Energy Corp. Announces First Quarter 2026 Financial Results and Williamsburg Joint Venture Agreement
Publié le 26/05/2026 à 12:05, il y a 1 heure MEXC Deploys 1,000 BTC to Strategic Reserves in March-April Security Report
Publié le 26/05/2026 à 11:45, il y a 1 heure 20 minutes Merach S29R2: The Self-Powered Exercise Bike Freeing Users from Monthly Fitness Subscriptions
Publié le 26/05/2026 à 10:08, il y a 2 heures 56 minutes Annual General Meeting on May 28, 2026: Deutsche Bank AG intends to reappoint EY as its auditor. Shareholders call on EY to take responsibility for the Wirecard scandal and submit a counter-motion
Publié le 26/05/2026 à 10:01, il y a 3 heures 4 minutes PNE AG: Subscription period for new corporate bond 2026/2031 launched via the German Stock Exchange
